Astraveus
Paris
About Astraveus
Astraveus is revolutionizing the field of CGT manufacturing with the Lakhesys™ platform, an end-to-end, cell foundry, that uses deep process optimization and single-use, microfluidic bioprocessors to deliver better results with reduced inputs. By removing the need for large-scale infrastructure, reducing costs, and overcoming the logistical challenges typically associated with CGT manufacturing, Astraveus is seeking to transform patient access to these life-changing therapies.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $38.7M
- Funding stage: Seed
- Last round: Debt Financing (Dec 2024)
- Website: astraveus.com
- Phone: [email protected]
Industries & Categories
Bioinformatics, Biotechnology, Life Science
Social Profiles
Canonical: https://fsome.com/organization/astraveus-59803 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.